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Background: We sought to assess the long-term value of dobutamine stress cardiovascular magnetic resonance (DCMR) for prediction of late 
cardiac events in a large cohort of patients with known or suspected coronary artery disease.
Methods: Clinical data and DCMR results were analyzed in 1466 consecutive patients undergoing DCMR. Ninety four patients lost to follow-up 
and three hundred fifty five patients who underwent early revascularization within 3 months of DCMR were excluded from analysis. The remaining 
1017 patients (median age, 62 years) were followed up for a mean of 44 ± 24 months. Wall motion abnormalities (WMA) at rest and the presence 
of stress-induced WMA (ischemia) were assessed for each patient. Cardiac events, defined as cardiac death and non-fatal myocardial infarction, 
were assessed. In patients with inducible WMA, following therapy (revascularization or medical therapy alone) post DCMR were related to clinical 
outcome.
Results: Forty six cardiac events were reported, documented cardiac death in 33 and nonfatal myocardial infarction in 13 patients. In those with 
and without inducible WMA, the proportion of patients with cardiac events were 8.0% versus 3.1%, respectively, (hazard ratio: 3.3; 95% confidence 
interval: 1.8 to 5.9 for the presence of inducible WMA; p<0.001). A normal DCMR carried a relatively good prognosis, with a 5-year event-free survival 
of 97.1%. Patients who underwent revascularization within 3 months of DCMR due to inducible WMA demonstrated a significant lower rate of cardiac 
events (5.1%) compared to patients with inducible WMA and medical therapy only (8.0%), p<0.001.
Conclusion: DCMR has an added value for predicting cardiac events during long-term follow-up. Patients who underwent early revascularization 
due to inducible WMA at DCMR demonstrate lower cardiac event rates compared to patients with medical therapy alone.
